Nature

Ørsted is the world’s largest developer of offshore wind power. Ingrid Reumert is a Senior Vice President with the company. She talks about designing wind farms with nature in mind to Brunswick Partner Wolfgang Blau…

Brunswick’s Phil Drew and Tarini Kumar talk to Morgan Gillespy, Executive Director of the Food and Land Use Coalition at the World Resources Institute, about an end-to-end systemic transition.

Preserving and restoring nature is a critical part of the climate solution. Brunswick asks two leaders of this effort to draw on their experience and highlight the role of business.

At a time when so many stories about the oceans are dispiriting, Brunswick spoke with five companies, large and small, that inspire a sense of hope.

Science-based targets revolutionized business action on climate. They’re poised to do the same for nature. Leaders from three businesses in the vanguard of this dizzyingly complex—and critical—work talk about shaping the new standards.

Revaluing nature can create both positive environmental impact and financial returns, writes Schroders CEO Peter Harrison.

In an excerpt from Jon Miller and Lucy Parker’s book The Activist Leader, the CEO of Nestlé explains why leading the transition to regenerative agriculture this decade is key to reaching net zero, and the…

Both the EU and UK are delaying passage of regulations on chemicals, creating a minefield for companies in many sectors. Brunswick’s Lidia Fornasiero and Nick Blow spoke to expert Darren Abrahams, Partner at international law…

Left holding the bag, they will correct the mistakes of their predecessors, says Brunswick’s Jennifer Huffman.

Corporate claims around climate change are coming under increasing scrutiny in Asia. A report co-written by the Asia Investor Group on Climate Change (AIGCC) outlines the steps companies and investors need to take to avoid…

Brunswick CEO Neal Wolin was interviewed at the Paris Peace Forum by Pauliina Murphy, from the World Benchmarking Alliance.

Not waiting for nature-positive standards, UK multinational GSK is taking action and a leadership role in the pharma and biotech sector. By Alastair Morton and Ellie Fallon.